text: OBJECTIVE: The aim of this study was to assess the efficacy and tolerability of nebulized << arformoterol tartrate >> (a selective, long-acting [[ beta(2)-adrenergic ]] agonist that is the [R,R] isomer of formoterol) and salmeterol xinafoate versus placebo in patients with chronic obstructive pulmonary disease (COPD).